Moderna, Inc. Human Resources Contracts & Agreements
17 Contracts & Agreements
- Bonus & Incentive Agreements (2 contracts)
- Compensation Agreements (4)
- Consulting Agreements (3)
- Employment Agreements (1)
- Retention Agreements (3)
- Separation Agreements (2)
- Severance Agreements (1)
- Transition Agreements (1)
- Amended and Restated Executive Severance Plan and Form of Participation Letter, as amended on February (Filed With SEC on February 24, 2023)
- Amended and Restated Non-Employee Director Compensation Policy, effective October 1, 2022 (Filed With SEC on November 3, 2022)
- Amended and Restated Non-Employee Director Compensation Policy, effective April 28, 2022 (Filed With SEC on August 3, 2022)
- Updated Executive Retirement and Strategic Consulting Agreement, dated May 27, 2022, between ModernaTX, Inc. and David Meline (Filed With SEC on June 1, 2022)
- Executive Separation Agreement and Release, dated May 13, 2022, between ModernaTX, Inc. and Jorge Gomez (Filed With SEC on May 13, 2022)
- Executive Retirement and Strategic Consulting Agreement by and between ModernaTX, Inc. and David Meline, dated as of April (Filed With SEC on May 4, 2022)
- Employment Letter Agreement between ModernaTX, Inc. and Shannon Klinger, dated as of March 4, 2021 (Filed With SEC on February 25, 2022)
- Consulting Agreement by and between ModernaTX, Inc. and Corinne Le Goff (Filed With SEC on February 25, 2022)
- Executive Separation and Transitional Services Agreement (Filed With SEC on February 25, 2022)
- Amended and Restated Non-Employee Director Compensation Policy, effective April 28, 2021 (Filed With SEC on May 6, 2021)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the 2018 Stock Option and Incentive Plan (Filed With SEC on May 6, 2021)
- Amended and Restated Executive Retention Agreement by and between the Company and Tal Zaks, dated as of February 23, 2021 (Filed With SEC on February 26, 2021)
- Executive Retention and Separation Agreement, dated May 5, 2020, by and between Moderna, Inc. and Lorence Kim, M.D (Filed With SEC on May 7, 2020)
- Executive Retention Agreement, dated March 29, 2020, by and between Moderna, Inc. and Tal Zaks, M.D (Filed With SEC on March 30, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2019)
- Strategic Advisor & Transition Agreement by and between ModernaTX, Inc. and John Mendlein, dated as of January 17, 2019 (Filed With SEC on March 13, 2019)
- 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on November 9, 2018)